Litcius/Paper detail

Extended dosing intervals of ixekizumab for psoriasis: A single-center, uncontrolled, prospective study

Li‐Ran Ye, Bing‐Xi Yan, Xueyan Chen, Si‐Qi Chen, Jiaqi Chen, Xiao‐Yong Man

2021Journal of the American Academy of Dermatology14 citationsDOIOpen Access PDF

Topics & Concepts

IxekizumabMedicinePsoriasisDosingSecukinumabDermatologyPsoriasis Area and Severity IndexInternal medicinePsoriatic arthritisPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesAsthma and respiratory diseases
Extended dosing intervals of ixekizumab for psoriasis: A single-center, uncontrolled, prospective study | Litcius